Advanced renal cell carcinoma and COVID-19 — a personal perspective

The management pathways of advanced renal cell carcinoma (RCC) have considerably evolved in the past 5 years, presenting a particular challenge during the coronavirus disease 2019 (COVID-19) pandemic. In this Comment, we propose a management algorithm on the basis of the current evidence to safely m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ged, Yasser, Markowski, Mark C., Pierorazio, Phillip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267767/
https://www.ncbi.nlm.nih.gov/pubmed/32494029
http://dx.doi.org/10.1038/s41585-020-0345-5
_version_ 1783541473865629696
author Ged, Yasser
Markowski, Mark C.
Pierorazio, Phillip M.
author_facet Ged, Yasser
Markowski, Mark C.
Pierorazio, Phillip M.
author_sort Ged, Yasser
collection PubMed
description The management pathways of advanced renal cell carcinoma (RCC) have considerably evolved in the past 5 years, presenting a particular challenge during the coronavirus disease 2019 (COVID-19) pandemic. In this Comment, we propose a management algorithm on the basis of the current evidence to safely manage patients with advanced RCC during this pandemic.
format Online
Article
Text
id pubmed-7267767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72677672020-06-03 Advanced renal cell carcinoma and COVID-19 — a personal perspective Ged, Yasser Markowski, Mark C. Pierorazio, Phillip M. Nat Rev Urol Comment The management pathways of advanced renal cell carcinoma (RCC) have considerably evolved in the past 5 years, presenting a particular challenge during the coronavirus disease 2019 (COVID-19) pandemic. In this Comment, we propose a management algorithm on the basis of the current evidence to safely manage patients with advanced RCC during this pandemic. Nature Publishing Group UK 2020-06-03 2020 /pmc/articles/PMC7267767/ /pubmed/32494029 http://dx.doi.org/10.1038/s41585-020-0345-5 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Ged, Yasser
Markowski, Mark C.
Pierorazio, Phillip M.
Advanced renal cell carcinoma and COVID-19 — a personal perspective
title Advanced renal cell carcinoma and COVID-19 — a personal perspective
title_full Advanced renal cell carcinoma and COVID-19 — a personal perspective
title_fullStr Advanced renal cell carcinoma and COVID-19 — a personal perspective
title_full_unstemmed Advanced renal cell carcinoma and COVID-19 — a personal perspective
title_short Advanced renal cell carcinoma and COVID-19 — a personal perspective
title_sort advanced renal cell carcinoma and covid-19 — a personal perspective
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267767/
https://www.ncbi.nlm.nih.gov/pubmed/32494029
http://dx.doi.org/10.1038/s41585-020-0345-5
work_keys_str_mv AT gedyasser advancedrenalcellcarcinomaandcovid19apersonalperspective
AT markowskimarkc advancedrenalcellcarcinomaandcovid19apersonalperspective
AT pieroraziophillipm advancedrenalcellcarcinomaandcovid19apersonalperspective

Ejemplares similares